Tag results:

survivin

An Organoid Model of Colorectal Circulating Tumor Cells with Stem Cell Features, Hybrid EMT State and Distinctive Therapy Response Profile

[Journal of Experimental & Clinical Cancer Research] Investigators generated organoids from circulating tumor cells isolated from an orthotopic colorectal cancer xenograft model.

Knockdown of YAP/TAZ Sensitizes Tamoxifen-Resistant MCF7 Breast Cancer Cells

[Biochemical and Biophysical Research Communications] Scientists found that the expression level of YAP/TAZ in tamoxifen-resistant MCF7 breast cancer cells was significantly increased compared with that in MCF7 cells.

IMV Announces First Patient Dosed in the VITALIZE Phase IIB Clinical Study Evaluating its Lead Compound, MVP-S, in Combination with KEYTRUDA® (pembrolizumab) in Patients...

[IMV Inc.] IMV, Inc., a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX platform to treat solid and hematologic cancers, announced a first patient dosed in the VITALIZE Phase IIB clinical trial.

Combined Effect of Heat Shock Protein Inhibitor Geldanamycin and Free Radicals on Photodynamic Therapy of Prostate Cancer

[Journal of Materials Chemistry B] The authors found that the inhibition of Hsp90 could inhibit the overexpression of its client proteins such as anti-apoptotic proteins and androgen receptor, thereby improving the efficacy of photodynamic therapy and inducing prostate cancer cell apoptosis.

STAT3 as a Target for Sensitizing Prostate Cancer Cells to Irradiation

[Radiation Research] Investigators demonstrated that STAT3 blockade with a STAT3 inhibitor or siRNA increased the radiosensitivity of prostate cancer (PCa) cells and that radiation together with STAT3 blockade induced more apoptosis and double-strand breaks than radiation alone in LNCaP cells.

Galactose-Decorated Liver Tumor-Specific Nanoliposomes Incorporating Selective BRD4-Targeted PROTAC for Hepatocellular Carcinoma Therapy

[Heliyon] Researchers suggested that galactosylated nanoliposomes incorporating ARV-825 was a novel actively targeted PROTAC-based nanotherapeutic approach for hepatocellular carcinoma.

Popular